Home Tags Pharmaceuticals
Evidence is mounting that psychedelic drugs can help treat diseases. Here are the most promising uses.
There's been a resurgence of interest in psychedelic drugs' potential to treat conditions like depression. Research is beginning to yield new treatments.
A UK drugmaker’s stock crashed 80% after it was indicted for a ‘truly shameful’ opioid-addiction scheme
Indivior's shares plunged 80% after the British drugmaker was indicted for deceiving doctors about Suboxone Film, its opioid-addiction treatment.
Gene therapy, a decades-old technology that targets disease at its genetic root, is coming of age. New startups are pouring into the space, and it's become a hot area for M&A.
Bayer's shares plunged 10% after a second jury found its Roundup weedkiller caused cancer.
Scientists just made marijuana compounds in a lab for the first time, and it could open the door to new treatments for devastating diseases
A team of UC Berkeley researchers made cannabis compounds THC and CBD in a lab using an approach known as synthetic biology. They've already licensed the technology to a startup called Demetrix.
The group of pharma executives tried to justify the cost of their drugs — and pointed fingers.
A depression drug that’s been called ‘the most important discovery in half a century’ just got a big step closer to FDA approval
Esketamine, a first-of-its-kind depression drug made by Johnson & Johnson, got a big nod on Tuesday from a group of experts convened by regulators.
Meet the Sacklers, one of the richest families in America, who built their $14 billion fortune off of controversial prescription drug OxyContin
The secretive family's $14 billion fortune comes mainly from sales of the prescription painkiller. They're also well-known for their philanthropic endeavors.
Walmart and CVS just resolved their $4 billion dispute over where you can pick up your prescriptions
People whose prescriptions are handled by CVS Caremark will still be able to pick them up at Walmart pharmacies, after the companies ended a pricing spat.
Vistin Pharma, known for its type-2 diabetes drug Metformin, said in March that it would try its hand at the energy market. Things didn't go to plan.